- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
New Survey by Greystone Associates Examines Technology, Therapeutic and Market Factors
Advances in nanotechnology that enable drugs to be delivered in ways that preserve their efficacy and to precise therapeutic targets are creating a host of opportunities for drug developers. A variety of nanostructures are being investigated as functional drug carriers for a wide range of therapies, most notably cardiovascular medicine, autoimmune diseases, and cancer.
While the concept of nanoparticles in drug delivery is not new, the number of research programs and active drug development projects has escalated as funding to nanotechnology developers has increased. The result is the emergence of a host of novel nanotechnologies tailored to meet the physicochemical requirements of drug developers.
Nanoparticles have already improved the availability and efficacy of some drugs, but the capabilities that evolving technologies possess will leads to a dramatic increase in the number of therapies delivered via nanoparticles. In many cases drugs in nanocrystalline form can be administered in smaller doses because they can be delivered directly to the tissue and in controlled doses related to the patient's personal requirements.
These findings are contained in a new and comprehensive report: Nanoparticle Drug Delivery: Technologies, Targets and Therapies. The survey concludes that nanoparticle-based drug delivery will gain traction at the expense of traditional drug formulation methods, particularly among emerging biologics.
About Greystone Associates
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
For more information, please click here
Copyright © Greystone AssociatesIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016
Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers